Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Quinazoline based EGFR inhibitors containing a zinc binding moiety

Quinazoline based EGFR inhibitors containing a zinc binding moiety

US Patent 8975401 · Granted Mar 10, 2015

Estimated economic value: $6,119,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Exosomal nucleic acid vaccine modularly configured to harness multiple antigen p2025
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety2023
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety2023
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety2023
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety2023
Fused amino pyridine as HSP90 inhibitors2023
Fused amino pyridine as HSP90 inhibitors2023
1,3-di-substituted ketene compound and application thereof2022
1,3-di-substituted ketene compound and application thereof2022
2,4-bis(nitrogen-containing group)-substituted pyrimidine compound, preparation 2022
2,4-bis(nitrogen-containing group)-substituted pyrimidine compound, preparation 2022
Phosphoinositide 3-kinase inhibitors with a zinc binding moiety2022